Sofosbuvir is an antiviral prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of chronic hepatitis C virus infection (HCV) in adults and children 3 years of age and older who meet specific requirements, as determined by a health care provider. It is grouped under the following drug class(es): Nucleotides. Its therapeutic use is listed as anti-infectives and antivirals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Hepcinat, Hepcvir, Resof and SoviHep. Its PubChem CID is 45375808.
Sofosbuvir
| CAS No | 1190307-88-0 |
|---|---|
| Molecular Formula | C22H29FN3O9P |
| Molecular Weight | 529.5 g/mol |
| Synonyms | propan-2-yl (2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
S. Food and Drug Administration (FDA) for the treatment of chronic hepatitis C virus infection (HCV) in adults and children 3 years of age and older who meet specific requirements, as determined by a health care provider.
The listed CAS number is 1190307-88-0.
The listed molecular formula is C22H29FN3O9P.
The listed molecular weight is 529.5 g/mol.
propan-2-yl (2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate.
The source lists Hepcinat, Hepcvir, Resof and SoviHep.